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Jean-Louis Vincent* and Fabio S. TacconeTherapeutic hypothermia or targeted temperature man-
agement (TTM) is widely used after cardiac arrest (CA)
in adult patients and improves survival and neurologic
outcome after out-of-hospital CA due to shockable
rhythms [1]. However, several issues, including the
optimal target temperature, the time to initiate cooling and
the most effective duration, remain controversial in this
setting [2]. In neonatal hypoxic encephalopathy, random-
ized controlled trials (RCTs) have shown that cooling
comatose newborn patients for 72 hours, especially when
brain damage has been demonstrated by altered electroen-
cephalographic findings, improves the proportion of
patients with an intact neurological recovery [3, 4]. The
results of clinical trials in the setting of pediatric CA are,
however, difficult to interpret because RCTs are lacking. A
recent meta-analysis of six studies (three retrospective and
three prospective cohort studies, total n = 356) showed that
the evidence supporting TTM in this setting was poor [5].
When we read the conclusions of the recent RCT by
Moler et al. [6], which investigated two early TTM strat-
egies (33.0 °C versus 36.8 °C) in 295 comatose children
after out-of-hospital CA, we initially considered it as a
negative trial providing more evidence against the brain-
protective effects of post-CA hypothermia in this subset
of patients. But when we read the paper more carefully,
we realized that perhaps a different conclusion could be
reached. Among the 260 children with available data on
outcome, 20 % of those cooled to 33.0 °C and 12 % of
those managed at 36.8 °C had an intact neurological re-
covery (p = 0.14). The p value is indeed 'non-significant',
but in real life, statistics may not tell the full story.
Although the analysis was conducted according to
our current methodological standards using rigorous
statistical evaluation, statistics are not always the only
relevant factor in real-life individual patient management;* Correspondence: jlvincen@ulb.ac.be
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each proposed strategy, also plays a role.
To try and highlight the clinical limitations of statistical
reliance when interpreting study results, imagine the
following conversation the next time you talk to parents
of a child who has had a CA:
Doctor: I’m really sorry, but your child may have
serious brain damage as a result of his cardiac arrest.
Parent: That’s terrible! Isn’t there anything we can do?
Doctor: I’m afraid not. There are some interventions
that have been suggested, but they’ve not been shown
to be effective.
Parent: What interventions?
Doctor: Well, cooling the body for a couple of days,
for example. It’s been tried in neonates with birth
asphyxia and adults after cardiac arrest.
Parent: But … if this intervention is used in neonates
and adults, how can you say it won’t work in
children?
Doctor: Well, in a recent study including almost 300
children, 20 % of those who were cooled survived
with good brain function versus just 12 % of those
who weren’t cooled. Neurological status improved in
38 % of the cooled children compared with only 29 %
of the non-cooled. And, 28 days after the arrest, the
mortality rate was 10 % lower in cooled children
(57 % versus 67 %). Unfortunately, when the researchers
applied the standard statistical rules that we use to
interpret all scientific research, there was more than a
10 % possibility that these differences were due to
chance, so we can’t recommend it.
Parent: But those results are really encouraging. Even
if statistics tell you that this may be due to chance,
there’s still the possibility that it wasn’t and I’d like my
child to have that opportunity. Maybe the treatment’s
expensive?
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Doctor: Quite safe actually. Potassium and platelet
levels went down a little, but with no harmful
consequences. There is a risk that the heart rhythm
can be affected; some of these abnormalities can even
be quite dangerous. In the same study, serious
abnormalities of the heart rhythm occurred in 11 % of
the cooled children and 9 % of the others. Reduction
in body temperature also increases the risk of
infections; the investigators of this study reported that
46 % of cooled children developed an infection,
compared with 39 % of the other children.
Parent: So, the treatment is associated with some risk
but can still improve the chances of my child
surviving… how can you balance the benefits and the
risks for my boy?
Doctor: Honestly, I don’t know. If I just have to use
numbers… 12 children would need to be cooled
instead of kept at normal temperature in order to
have one additional child with a good clinical
outcome. And, 15 children would need to be cooled
for one child to develop an infection.
Parent: Please, try this treatment on my child.
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